Wearables & Connected Devices
Revolutionize non-identified patient data collection with connected devices
The opportunity to seamlessly integrate non-identified patient data into the drug development process and improve outcomes is here – and IQVIA can help.
By harnessing the IQVIA CORE™, our device-agnostic platform provides you with real-time data and endpoints – direct from your patients – and helps you
- Accelerate clinical development. Fast assessment of glucose-related safety issues, fewer required SMBG measurements, and data acceptability reports with Continuous Glucose Monitoring (CGM) devices
- Enhance patient safety and engagement. Improved patient engagement with eCOA solutions directly on the patients’ mobile devices, no device provisioning required
- Increase commercial value. Reduced cardiac safety study costs up to 30% with ECG device-agnostic data intake technology
Find out how to revolutionize your approach to patient data.